News

Filter

Current filters:

NeurologicalVyvanse

1 to 9 of 23 results

Shire awards 10,000 euros to ADHD patient groups

Shire awards 10,000 euros to ADHD patient groups

13-10-2014

Ireland-based pharma company Shire announced the winners of the 2014 Excellence in ADHD Patient Group…

Adderall XREuropeHealthcareIrelandNeurologicalPharmaceuticalShireVyvanse

Shire gets priority review for its Vyvanse sNDA in binge eating from FDA

Shire gets priority review for its Vyvanse sNDA in binge eating from FDA

15-09-2014

Ireland-headquartered drugmaker Shire has received acceptance for its filing with priority review for…

AbbVieIrelandNeurologicalPharmaceuticalRegulationShireVyvanse

Shire gets positive ruling on Vyvanse patents from US district court

25-06-2014

Ireland-headquartered drugmaker Shire, which is defending itself from a $46 billion unsolicited bid from…

ActavisAmneal PharmaLegalMylanNeurologicalPatentsPharmaceuticalRoxaneSandozShireUSAVyvanse

Shire agrees to FDA call for pediatric trials of Vyvanse for ADHD

Shire agrees to FDA call for pediatric trials of Vyvanse for ADHD

12-06-2014

Ireland-headquartered drugmaker Shire says it has agreed to a written request by the US Food and Drug…

NeurologicalPharmaceuticalRegulationResearchShireUSAVyvanse

Shire will drop MDD indication for Vyvanse after failed endpoints in Ph III

07-02-2014

Shares of Ireland-headquartered Shire fell 2.4% to £30.67 in early trading, after the company presented…

NeurologicalPharmaceuticalResearchShireVyvanse

Added benefit of lisdexamfetamine not proven, says German watchdog

03-09-2013

Ireland-headquartered Shire's (LSE: SHP) Elvanse (lisdexamfetamine dimesylate) demonstrated no added…

ElvanseEuropelisdexamfetamine dimesylateNeurologicalPharmaceuticalPricingRegulationShireVyvanse

US FDA adds new indication for Shire's ADHD drug Vyvanse; 1st-qtr results

02-05-2013

Ireland-headquartered Shire (LSE: SHP) says that the US Food and Drug Administration has approved its…

FinancialNeurologicalNorth AmericaPharmaceuticalRegulationShireVyvanse

Shire agrees to settlement with US government over ADHD drug marketing

04-02-2013

Ireland-headquartered drugmaker Shire (LSE: SHP) said on Friday that it has reached an agreement in principle…

Adderall XRDaytranaFinancialLegalNeurologicalNorth AmericaPharmaceuticalShireVyvanse

1 to 9 of 23 results

Back to top